With Illumina (ILMN +44.8%) shares trading 23% above Roche's (RHHBY.PK) $44.50/share hostile bid...

|By:, SA News Editor

With Illumina (ILMN +44.8%) shares trading 23% above Roche's (RHHBY.PK) $44.50/share hostile bid price, investors clearly expect a better offer to arrive. Auriga (Buy) considers Roche's initial offer an "opportunistic" move spurred by Illumina's recent woes, and believes a stabilizing business will force Roche to make a higher bid. (more)